We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.15%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$474M
AUM Growth
+$427M
Cap. Flow
+$433M
Cap. Flow %
91.18%
Top 10 Hldgs %
10.55%
Holding
454
New
296
Increased
64
Reduced
55
Closed
20

Top Buys

Rank Stock Value
1
OXLC
Oxford Lane Capital
OXLC
+$6.86M
2
BBDC icon
Barings BDC
BBDC
+$6.33M
3
OXSQ icon
Oxford Square Capital
OXSQ
+$5.45M
4
ECC
Eagle Point Credit Company
ECC
+$5.29M
5
FSK icon
FS KKR Capital
FSK
+$5.24M

Top Sells

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$2.25M
2
ACOR
Acorda Therapeutics
ACOR
+$644K
3
ARRY
Array Biopharma Inc
ARRY
+$605K
4
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$603K
5
QURE icon
uniQure
QURE
+$374K

Sector Composition

Rank Sector Weight
1 Financials 23.58%
2 Real Estate 14.99%
3 Energy 13.55%
4 Healthcare 12.23%
5 Materials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KTB icon
426
Kontoor Brands
KTB
$4.62B
$6K ﹤0.01%
+203
New +$6.03K
IQ icon
427
iQIYI
IQ
$1.18B
$5K ﹤0.01%
+229
New +$4.73K
GGB icon
428
Gerdau
GGB
$9.44B
$4K ﹤0.01%
+1,285
New +$3.77K
EMBJ
429
Embraer S.A. ADS
EMBJ
$11.6B
$3K ﹤0.01%
170
-114
-40% -$2.2K
TME icon
430
Tencent Music
TME
$14.5B
$3K ﹤0.01%
+213
New +$3.37K
INFY icon
431
Infosys
INFY
$45B
$2K ﹤0.01%
+151
New +$1.6K
MOMO
432
Hello Group
MOMO
$869M
$2K ﹤0.01%
67
– –
RDY icon
433
Dr. Reddy's Laboratories
RDY
$9.82B
$2K ﹤0.01%
+235
New +$1.85K
JOBS
434
DELISTED
51job Inc
JOBS
$2K ﹤0.01%
+30
New +$2.4K
AAP icon
435
Advance Auto Parts
AAP
$3.37B
– –
-92
Closed -$16K
ADAP
436
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-50,655
Closed -$218K
ASRT
437
DELISTED
Assertio
ASRT
– –
-1,072
Closed -$326K
CRNX icon
438
Crinetics Pharmaceuticals
CRNX
$8.86B
– –
-7,934
Closed -$181K
EWBC icon
439
East-West Bancorp
EWBC
$17.9B
– –
-339
Closed -$16K
INO icon
440
Inovio Pharmaceuticals
INO
$79.8M
– –
-4,412
Closed -$197K
ISRG icon
441
Intuitive Surgical
ISRG
$121B
– –
-96
Closed -$18K
IVZ icon
442
Invesco
IVZ
$13.3B
– –
-952
Closed -$18K
KNSA icon
443
Kiniksa Pharmaceuticals
KNSA
$4.83B
– –
-11,763
Closed -$212K
META icon
444
Meta Platforms (Facebook)
META
$1.51T
– –
-435
Closed -$73K
MRKR icon
445
Marker Therapeutics
MRKR
$20.3M
– –
-3,967
Closed -$262K
OPTN
446
DELISTED
OptiNose
OPTN
– –
-2,300
Closed -$355K
STIM icon
447
Neuronetics
STIM
$120M
– –
-13,535
Closed -$206K
WDAY icon
448
Workday
WDAY
$33.4B
– –
-80
Closed -$15K
ACOR
449
DELISTED
Acorda Therapeutics
ACOR
– –
-404
Closed -$644K
APTX
450
DELISTED
Aptinyx Inc. Common Stock
APTX
– –
-12,427
Closed -$50K
15 16 17
18
19

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, Virtus ETF Advisers held 454 positions worth $474M, up 909% from $47M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Virtus ETF Advisers deployed $433M of net new capital in Q2 2019, opening 296 new positions and adding to 64 existing holdings. Its largest new stake was Oxford Lane Capital: 132,284 shares worth $6.67M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 0.73% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Array Biopharma Inc, an estimated $605K trimmed.

  • Virtus ETF Advisers's largest Q2 2019 buy was Oxford Lane Capital: 132,284 shares worth $6.67M.
  • Virtus ETF Advisers added most to Dominion Energy in Q2 2019, an estimated $2.63M increase.
  • Virtus ETF Advisers's biggest Q2 2019 reduction was Array Biopharma Inc, cutting an estimated $605K.
  • Virtus ETF Advisers fully exited Spark Therapeutics, Inc. Common Stock in Q2 2019, selling an estimated $2.25M.
  • Virtus ETF Advisers's ten largest holdings make up 11% of its $474M portfolio in Q2 2019.
  • Virtus ETF Advisers opened 296 new positions and closed 20 in Q2 2019.
  • Virtus ETF Advisers's portfolio value rose 909% quarter-over-quarter to $474M.

Based on Virtus ETF Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.